Four new neo-clerodane diterpenoids, scutebarbatines W-Z (1-4), were isolated from the ethanol extract of Scutellaria barbata (Labiatae), and their structures were elucidated on the basis of extensive spectroscopic studies. In addition, the proposed structures of at least seven 13-spiro subtype neo-clerodanes: scutehenanine B (5), scutebarbatine G (6), 6-O-nicotinoylscutebarbatine G (7), barbatin A (8), 6,7-di-O-nicotinoylscutebarbatine G (9), 6-O-nicotinoyl-7-O-acetylscutebarbatine G (10), and scutebarbatine F (11), reported by Dai and co-workers from the same species, were incorrectly assigned and have been revised by reanalysis of the published NMR data.
Species of the genus Scutellaria (family Labiatae) are deemed as the source of the most potent neo-clerodane insect antifeedants known so far, and over 150 neo-clerodane diterpenoids have been isolated from this genus, which makes them potentially useful as ecologically acceptable agents for pest control. 1) Recently, a series of cytotoxic neo-clerodanes were reported from Scutellaria barbata-a traditional Chinese herbal medicine named "Ban Zhi Lian." [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] As part of BioBioPha to assemble a large-scale natural compound library which is very valuable in the discovery of new lead compounds from nature, [15] [16] [17] [18] [19] further chemical investigation on S. barbata afforded four new neo-clerodane derivatives, scutebarbatines W-Z (1-4) ( Fig. 1) , along with nine known neo-clerodanes, scutebatas A-C, 13) scutebatas E-G, 11, 13) scutebarbatines A and B, 2, 4) and 6-O-nicotinoylbarbatin C. 6) Furthermore, the structures of at least following seven 13-spiro neo-clerodanes: scutehenanine B (5), 10) scutebarbatine G (6), 5) 6-O-nicotinoylscutebarbatine G (7), 9) barbatin A (8), 4) 6,7-di-O-nicotinoylscutebarbatine G (9), 5) 6-Onicotinoyl-7-O-acetylscutebarbatine G (10), 5) and scutebarbatine F (11), 3) continuously reported by Dai and co-workers from the same plant, were incorrectly assigned and have been revised. Herein, we report the structure elucidation of new compounds as well as structure revision of some analogues.
Results and Discussion
Compound 1, obtained as amorphous powder, had a molecular formula of C 33 H 37 NO 8 11, 13) this compound should be a neo-clerodane diterpenoid with a 3-en-13-spiro-15,16-g-lactone moiety. The heteronuclear multiple bond coherence (HMBC) correlations (Fig. 2 ) allowed us to position the benzoyloxy and nicotinoyloxy groups at C-1 and C-6, respectively. On account of almost overlapping (d C 165.66, 165.62) of two aromatic ester carbonyl carbon signals in CDCl 3 , it is very necessary to change the deuterated solvent (d C 167.2, 166.1 in CD 3 OD) for unambiguous assignment of the two aromatic substitutes by HMBC spectrum.
The relative configuration of 1 was deduced from its rotating frame Overhauser effect spectroscopy (ROESY) spectrum (Fig. 2 ). The observable correlations of H-7↔Me-17, Me-19 and Me-20; H-1↔Me-19 and Me-20, indicated that these protons were cofacial and a-oriented, whereas the correlation of H-6↔H-10 was indicative of their b-orientation. The configuration of C-13 was determined to be R* by the ROESY correlation of Me-17↔H-14a, and the more detailed ROESY information was summarized in Fig. 2 . Accordingly, the structure of 1 was elucidated as (13R*)-1b-benzoyloxy6a -nicotinoyloxy-7b -hydroxy-8b ,13-epoxy-3-neo-cleroden-15,16-olide, named scutebarbatine W.
Generally, when no substitution happens in the rings C and D, there is a reliable and more convenient method to determine the configuration at C-13, which can be achieved just by observation of the diagnostic 1 H-and 13 C-NMR signals in The rule can efficaciously assign the configuration at C-13 of this subtype of neo-clerodanes. By chance, scutebarbatine W (1) was found to be contaminated by a trace amount of the C-13 epimer (13S* form) in our current study, in addition, more minor C-13 epimers can be also detectable in the NMR spectra (see supporting information in ref. 13 ) of scutebatas D, E and F. Recently, Dai and co-workers uninterruptedly reported many new neo-clerodanes from the same plant. [3] [4] [5] [6] [7] [8] [9] [10] 14) However, the authors proposed a series of wrong structures because of failure to comprehend NMR information, especially the application of HMBC correlations and the calculation of coupling constants. Now scutehenanine B (5) 10) is chosen to discuss its structure revision. Compound 5 is found to be identical with 1, and the conclusion is based on the following forceful evidence or reasons: 1) the NMR data (see supporting information in ref. 10 ) are in complete accord with those of 1; 2) the authors did not accurately handle the HMBC and ROESY correlations, and did not know how to calculate coupling constants of complex signals, for example, the proton signal at d H 5.77 is a legible ddd coupling and not so-called double doublet with Jϭ12.2, 3.5 Hz; 3) because of almost overlapping of two aromatic ester carbonyl carbons in CDCl 3 , the ester carbonyl signal of the benzoyloxy group can not be observed at d C 165.9 and was imaginary. According to the above discussion and combining the reported NMR data, the nicotinoyloxy group at C-11 and the spirocarbon configuration of scutebarbatine G (6) 5) and 6-O-nicotinoylscutebarbatine G (7) 9) should be adjusted to at C-1 and as 13R* form, respectively. Similarly, the substitute at C-11 in barbatin A (8), 4) 6,7-di-O-nicotinoylscutebarbatine G (9) 5) and 6-Onicotinoyl-7-O-acetylscutebarbatine G (10) 5) should be all repositioned at C-1, and the original assignment of scutebarbatine F (11) 3) is more unimaginable and should be revised as shown in Fig. 3 . Among them, 6-O-nicotinoyl-7-O-acetylscutebarbatine G (10) and scutebarbatine F (11) are actually identical with subsequently reported barbatine D 11) and barbatine C 11) (ϭscutebata F), 13) respectively. The structural revision of 5-11 has been summarized in Fig. 3 .
Scutebarbatine X (2), obtained as amorphous powder, had the molecular formula C 34 H 38 N 2 O 10 according to its positive HR-ESI-MS at m/z 657.2425 (Calcd for C 34 H 38 N 2 O 10 Na, 657.2424). The 1 H-and 13 C-NMR spectra (Table 1) bearing two nicotinoyloxy and one acetoxy groups were very similar to those of scutebatas A and B, 13) which suggested that 2 was a 6,7,8,11,14-pentaoxygenated 3,13-neo-clerodadien-15,16-olide derivative. The HMBC correlations allowed us to position the two nicotinoyloxy and one acetoxy groups at C-6, C-7 and C-11, respectively. By comparing the ROESY spectrum with reported, the relative configuration of C-6, C-7 and C-11 was found to be the same as those of scutebatas A and B. Therefore, the structure of 2 was determined as (11S*)-6a ,7b -dinicotinoyloxy-8b ,14-dihydroxy-11-acetoxy-3, 2 Hz) to the carbon at d C 166.0 (s), were observed, therefore the newly arisen benzoyloxy group was assigned to C-6. The relative configuration of 3 was deduced to be the same as those of scutebarbatines A and B based on their accordant NMR data (including coupling constants) and similar optical rotation behavior. 2, 4, 11) Thus the structure of 3 was established as 6a-benzoyloxy-7b -nicotinoyloxy-8b -hydroxy-3,11(E), 13- (Table 1) The above NMR character allowed us to make a conclusion that this compound was a 6,7-dioxygenated 3,13-neo-clerodadien-15,16-olide derivative. The strong HMBC correlations from the proton at d H 5.03 (1H, d, Jϭ9. 6 Hz, H-6) to the carbons at d C 141.5 (s, C-4), 17.6 (q, C-19) and 166.3 (s) indicated that the nicotinoyloxy group was located at C-6. The relative configuration of C-6 and C-7 was in accordance with those of 1-3 based on the similarity of their H-6/H-7 coupling constants. As a result, the structure of 4 was determined as 6a-nicotinoyloxy-7b-hydroxy-3,13-neo-clerodadien-15,16-olide.
Experimental
General Experimental Procedures Optical rotations were measured on a Jasco P-1020 (Jasco International Co., Ltd., Tokyo, Japan) automatic digital polarimeter. IR spectra were recorded using a Bruker Tensor 27 FT-IR (Bruker Optics GmbH, Ettlingen, Germany) spectrometer with KBr pellets. UV data were obtained from online HPLC analysis. NMR spectra were carried out on either a Bruker DRX-500 or AV-400 (Bruker BioSpin GmbH, 
